Secondary Logo

Journal Logo

Original Article

Profile and Correlates of Health-related Quality of Life in Chinese Patients with Coronary Heart Disease

Wang, Ling1; Wu, Yi-Qun1; Tang, Xun1; Li, Na2; He, Liu3; Cao, Yang4; Chen, Da-Fang1; Hu, Yong-Hua1,

Author Information
doi: 10.4103/0366-6999.160486
  • Free

Abstract

INTRODUCTION

Coronary heart disease (CHD) is the second leading cause of death among Chinese adults now-a-day.[1] Health-related quality of life (HRQoL) is useful for assessing the socio-economic impact and burden of illness, effectiveness of interventions and treatments, and long-term mortality among patients after a cardiac event.[23] So far, only a few studies assessed the HRQoL of Chinese CHD patients, yielding inconsistent results. The purpose of this study was to evaluate HRQoL outcomes of CHD patients in China using European Quality of Life 5-dimensions (EQ-5D) questionnaire and identify important HRQoL factors for this special population.

METHODS

Study population

This was a cross-sectional study conducted from August to October, 2010 in rural communities of Fangshan District, Beijing, China, using a stratified cluster sampling technique. Eligible subjects are native residents aged 40 years or older living locally for at least 5 years, with a confirmed diagnosis of myocardial infarction or angina by a class-two or higher hospital with electrocardiography findings, or a surgical history of coronary revascularization, coronary artery bypass or coronary stent implantation. Subjects who were unable to answer the questionnaire and take part in physical examination personally were excluded. This work was approved by the Ethics Committee of Peking University Health Sciences Center. Written informed consent was signed by each participant prior to data collection.

Study measures

All questionnaires were administered through personal interview, information collected on socio-demographic characteristics (age, sex, marital status, educational level, the family's population, household income per month), lifestyle factors (physical activity, cigarette smoking and alcohol consumption) and comorbidities, including hypertension, type 2 diabetes mellitus (T2DM) and stroke. Education level was categorized by whether junior high school was attended or not. Marital status is divided into married and unmarried (including single, divorced or widowed). Smokers were divided into rare/never smokers, past smokers or current smokers. Rare/never smokers were those who had smoked <100 cigarettes lifetime. Past smokers were those who had smoked more than 100 cigarettes in the past but had quit smoking during the last month. Current smokers were those who had smoked at least 100 cigarettes and had smoked during the last month. Drinking status was defined as nondrinkers, past drinkers and current drinkers. Nondrinkers were defined as those who never drank more than once a week. Past drinking was defined as consuming alcohol at least once a week in the past but not in the previous month. Current drinking was defined as drinking at least once per week and still drank at that frequency in the previous month. The average daily intake of current drinkers was calculated by dividing the total weekly amount of pure alcohol by 7 days. According to the daily intake of alcohol, current drinkers were categorized into four groups: Low, moderate, high, and very high group (for men ≤40, 41–60, 61–100 and >100 g/d, for women ≤20, 21–40, 41–60 and >60 g/d) as described in the World Health Organization's guide.[4] Physical activity was defined as performing physical exercise for at least 30 min at least once per week during the previous 6 months, not including housework or job-related work. The frequency of physical activity was measured as: Rarely/never, 1–4 times/week or ≥5 times/week. Household income per month (in renminbi, RMB) was classified as 3000 RMB or higher, 2000–2999 RMB, 1500–1999 RMB, and <1500 RMB for first- to fourth-class rural areas, respectively. Classification for body mass index (BMI) was: Underweight as BMI ≤18.5, normal weight as BMI 18.5–24.9, overweight as BMI 25.0–29.9 and obesity as BMI ≥30.0. Subjects were defined as having hypertension if they were taking antihypertensive medications and/or having systolic blood pressure (BP) ≥140 mmHg, or diastolic BP ≥90 mmHg. Subjects were considered as having T2DM if they had been diagnosed as T2DM in hospitals, or self-reported current treatment with insulin or oral hypoglycemic drugs. Subjects were defined as having a stroke if they had a history of language or physical dysfunction continuing for more than 24 h and diagnosed using computerized tomography or magnetic resonance imaging. Body weight was measured without heavy clothes and shoes to the nearest 0.1 kg by a calibrated weighing scale and height was measured barefoot using a fixed stadiometer to the nearest 0.1 cm. BMI is calculated as the ratio of weight to height squared (kg/m2). Health-related quality of life was measured by the EQ-5D scales, developed by the EuroQol Group (www.euroqol.org), well-validated and reliable in different cultures and various diseases including cardiac disease.[567] The EQ-5D descriptive system consists of five dimensions of health on mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.[8] Each dimension has three levels of response (no problems, moderate problems, and severe problems), level 1 (no problems) was coded as a “1” and level 2 (moderate problems) was coded as a “2” and level 3 (severe problems) was coded as a “3.” For example, state 11111 indicates no problems on any of the 5 dimensions. The EQ-5D index score was generated by applying societal preference weights to each of the above five health dimensions according to a Japan population-based time trade-off model[9] and was calculated by adding up the weighted scores for all five dimensions.

European Quality of Life 5-dimensions also includes a separate 20 cm EQ Visual Analog Scale (EQ-VAS) to measure self-assessed health status. Respondents were asked to indicate how good or bad his/her own health state on the day of assessment on a 100-point scale, the end-points of which were labeled “best imaginable health state” and “worst imaginable health state” anchored at 100 and 0 (rather like a thermometer), respectively.[7] This information can be used as a quantitative measure of health as judged by the individual respondents.

The compliance with drug treatment was evaluated in CHD patients by the Morisky-Green test,[5] which is a 4-item Medication Adherence Questionnaire (MAQ) containing the following questions: (1) Have you ever forgotten to take your medicines? (2) Were you careless at times about taking your medicines? (3) When you felt better, did you sometimes stop taking your medicines? (4) Sometimes, if you felt worse, did you stop taking your medicines? Score 1 for answering NO to each of four questions and 0 for choosing YES. Total scores range from 0 to 4. Score equal to four points means good compliance and score less than four points means poor compliance.

Statistical analyses

Health quality was measured by EQ-5D index and EQ-VAS scores and compared using one-way ANOVA or t-test among groups defined by sex, age, education level, marital status, household income per month, family's population, BMI, physical activity, smoking status, drinking status, comorbidities, compliance with drug treatment and the five dimensions of EQ-5D. The dimensions of EQ-5D were dichotomized as “no problems” versus “moderate/severe problems.” Continuous variables were presented as the means with standard deviations, and categorical variables were presented as percentages. Stepwise multiple linear regression and unconditional logistic regression were used to explore the determinants of health quality using sex, age, education level, marital status, monthly household income, family's population, BMI, physical activity, smoking status, alcohol drinking, comorbidities, compliance with drug treatment and duration of CHD as independent variables. Regression coefficients and standard regression coefficients were obtained from multiple linear regression models. Odds ratios (ORs) and 95% confidence intervals (CIs) were obtained from logistic regression analysis. Analyses were performed using SPSS version 22.0 (IBM Corp., Armonk, NY, USA), a P < 0.05 as statistically significant.

RESULTS

There were 1989 eligible CHD patients, of whom 1928 completed the questionnaires, aged 40–88 (mean age 61.64 ± 9.24) years, 29.4% men and 70.6% women, and were enrolled for further analysis, with a response rate of 96.9%. Duration of CHD ranged from 1 to 44 (median 3, 25th–75th percentiles 2–7) years.

The mean score of EQ-5D index was 0.889 ± 0.172, EQ-VAS score 71.56 ± 17.65. Among the five domains of HRQoL, anxiety/depression problem occurred in the lowest proportion of 7.9% patients, whereas pain/discomfort problem took the largest proportion of 24.3%.

Study variables and the HRQoL scores of CHD subjects were presented and compared as shown in Table 1. Although sex, comorbidity of hypertension, and compliance with drug treatment had no association with either EQ-5D index or EQ-VAS scores (P > 0.05), significant associations were observed among other demographic and related variables (P < 0.05).

T1-2
Table 1:
Relationship between study variables and HRQoL of CHD patients

Multiple linear regression results in Table 2 show that older age and stroke were negatively associated with a low EQ-5D index. Physical activity, household income per month, alcohol drinking, and family's population were positively related to high EQ-5D index. Diabetes mellitus and stroke were negatively associated with low EQ-VAS scores. Being married, physical activity, alcohol drinking, and family's population were positively relevant with improving EQ-VAS scores.

T2-2
Table 2:
Stepwise multiple linear regression analysis for the determinants of HRQoL in CHD patients

Logistic regression was performed for the five dimensions of EQ-5D to determine dimension-specific factors related to HRQoL. ORs, 95% CI and P values are presented in Table 3. Compared to patients of age <50 years, patients of age ≥80 years had more problems in mobility (OR = 3.236), usual activities (OR = 3.440), pain/discomfort (OR = 2.802), and anxiety/depression (OR = 6.935). Patients aged 70–79 years met with more problems in usual activities (OR = 2.151), whereas patients of 50–59 or 60–69 years experienced more problems in anxiety/depression (OR = 2.934 and OR = 3.379, respectively). Compared to patients with normal weight, obese patients (BMI ≥30 kg/m2) had more problems in mobility (OR = 1.632) and pain/discomfort (OR = 1.633), whereas underweight patients (BMI ≤18.5 kg/m2) had more problems in pain/discomfort (OR = 2.431). Patients with stroke were more likely to exhibit problems in self-care (OR = 2.121), usual activities (OR = 1.976) and mobility (OR = 1.465), whereas patients with diabetes mellitus were more likely to have problems in anxiety/depression (OR = 1.774). Physical activity had positive effects on mobility (1–4 times/week: OR = 0.462; ≥5 times/week: OR = 0.495), self-care (1–4 times/week: OR = 0.457; ≥5 times/week: OR = 0.354), usual activities (1–4 times/week: OR = 0.332; ≥5 times/week: OR = 0.475) and pain/discomfort (1–4 times/week: OR = 0.517; ≥5 times/week: OR = 0.760). Patients living with 2, 3–5 or >6 family members experienced less problems in mobility (OR = 0.505, OR = 0.318 and OR = 0.424, respectively). Past smoking had negative effects on mobility (OR = 1.983), self-care (OR = 2.592), usual activities (OR = 2.613) and pain/discomfort (OR = 1.971). Low-, medium-, and high-alcohol drinking were associated with less problems in mobility (OR = 0.373, OR = 0.286 and OR = 0.097, respectively). Past and medium alcohol drinkers had less problems in self-care (OR = 0.276 and OR = 0.193, respectively). Medium alcohol drinking is relevant with better usual activities (OR = 0.308). High education level was protective factors for self-care (OR = 0.575). Compared to patients with monthly household income <1500 RMB, patients with 2000–2999 or ≥3000 RMB reported less problems in usual activities (OR = 0.505 and OR = 0.430, respectively), those with 2000–2999 RMB suffering less pain/discomfort (OR = 0.544).

T3-2
Table 3:
Logistic regression analysis for dimension-specific factors related to HRQoL in CHD patients

DISCUSSION

Several studies[101112131415] indicated that smoking, increasing age, lower education level, less household income, and comorbid stroke or diabetes mellitus were related to deteriorated HRQoL of CHD patients, which was similar to our study. Our results revealed no significant gender discrepancy in overall HRQoL of CHD subjects. This is inconsistent with previous studies[16171819] which showed worse HRQoL of female CHD patients compared to male patients and may be partly due to a skewed sex ratio (male 29.4%, female 70.6%) in our study population, as a result of most skilled men working away in other cities, which is a common phenomenon in rural China.

So far, the relationship between BMI and quality of life in patients with CHD has not been particularly well-illustrated. Several studies have shown that being overweight or obese (BMI ≥25 kg/m2) was associated with greater survival in coronary artery disease patients compared to normal or “ideal” BMI, known as the “obesity paradox” or “reverse epidemiology.”[202122232425] Our findings were not in line with “obesity paradox,” showing that obese patients (BMI ≥ 30 kg/m2) had more problems in mobility (OR = 1.632, P = 0.014) and pain/discomfort (OR = 1.633, P = 0.006), similar to previous reports[1726] which suggested that HRQoL was impaired in CHD patients with obesity compared to patients with a normal BMI. Our results also indicated that underweight patients (BMI ≤18.5 kg/m2) reported more problems in pain/discomfort (OR = 2.431, P = 0.022) and exhibited the worst EQ-5D index in comparison to normal and overweight patients. This discrepancy may be attributed to different body composition among the study population, as well as effects of body fat and fat-free mass on HRQoL.

Previous studies have demonstrated a J- or U-shaped association between alcohol drinking and the risk of CHD. However, not all the studies replicated such type of association.[2728] In our study, certain alcohol drinking was related to better HRQoL, as patients with medium or high drinking had less problems in mobility, self-care and usual activities, consistent with previous reports.[2930] A recent study revealed that moderate alcohol intake related to improved HDL-cholesterol, fibrinogen and markers of glucose metabolism, implicating reduced CHD risk of moderate drinkers. Heavy and binge drinking were also associated with favorable levels of CHD biomarkers,[31] and this may be a possible explanation for the negative relationship between alcohol drinking and CHD risk.

Several limitations can be noted in the present study. First, the study used a cross-sectional design and could not show the effects of changes in demographic and related factors over time on HRQoL and provide causal information. We focused on the quality of life of CHD patients and a control group without CHD was not included. Thus, the results may not be specific for this special population. Second, because of data availability, we were unable to obtain treatments received for CHD, cardiac function, revascularization method and other clinical factors that may influence HRQoL. Third, there are more women than men in our study and selection bias may occur since generally men are affected more by CHD than women.

The strength of our study lies in its focus on the HRQoL of CHD patients in China and was carried out in representative residents of the rural Northern Han Chinese. Our data will be useful for future research in this field, and may provide more valuable information on HRQoL in patients with CHD when combined with other questionnaires, for example, questionnaires of Seattle Angina Questionnaire, Social Support Scale, and Self-rating Depression Scale.

In summary, this study suggests that older age, comorbid diabetes mellitus and stroke, obesity, underweight, less income, living alone, smoking, less physical activity, and lower education level are negative correlates of impairment of HRQoL in CHD patients. Being married, having more physical activity, moderate alcohol drinking and big family are protective factors for HRQoL in CHD patients. Clinicians could pay more attention to CHD patients with these characteristics so as to optimize care and improve quality of life in this special population. Further large-scale cohort studies should be conducted to confirm our results in the future.

REFERENCES

1. He L, Tang X, Song Y, Li N, Li J, Zhang Z, et al Prevalence of cardiovascular disease and risk factors in a rural district of Beijing, China: A population-based survey of 58,308 residents BMC Public Health. 2012;12:34
2. Wiklund I. Evaluation of quality of life in coronary heart disease Methods Find Exp Clin Pharmacol. 1996;18(Suppl C):37–8
3. Westin L, Nilstun T, Carlsson R, Erhardt L. Patients with ischemic heart disease: Quality of life predicts long-term mortality Scand Cardiovasc J. 2005;39:50–4
4. World Health Organization. . World Health Organization 2000 International Guide for Monitoring Alcohol Consumption and Related HarmLast accessed on 2013 Aug 13 Available from: http://www.whqlibdoc.who.int/hq/2000/who_msd_msb_00.4.pdf
5. Schweikert B, Hahmann H, Leidl R. Validation of the EuroQol questionnaire in cardiac rehabilitation Heart. 2006;92:62–7
6. Rabin R, de Charro F. EQ-5D: A measure of health status from the EuroQol Group Ann Med. 2001;33:337–43
7. Nowels D, McGloin J, Westfall JM, Holcomb S. Validation of the EQ-5D quality of life instrument in patients after myocardial infarction Qual Life Res. 2005;14:95–105
8. EuroQol Group. . EuroQol – A new facility for the measurement of health-related quality of life Health Policy. 1990;16:199–208
9. Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, et al Estimating an EQ-5D population value set: The case of Japan Health Econ. 2002;11:341–53
10. De Smedt D, Clays E, Annemans L, Doyle F, Kotseva K, Pajak A, et al Health related quality of life in coronary patients and its association with their cardiovascular risk profile: Results from the EUROASPIRE III survey Int J Cardiol. 2013;168:898–903
11. Shah BS, Deshpande SS. Coronary artery disease, diabetes, and health-related quality of life: Findings of a cohort study from India Value Health. 2013;16:A535–6
12. Lee HT, Shin J, Lim YH, Kim KS, Kim SG, Kim JH, et al Health-related quality of life in coronary heart disease in Korea: The Korea national health and nutrition examination survey 2007 to 2011 Angiology. 2015;66:326–32
13. Wang W, Lau Y, Chow A, Thompson DR, He HG. Health-related quality of life and social support among Chinese patients with coronary heart disease in mainland China Eur J Cardiovasc Nurs. 2014;13:48–54
14. Southern DA, McLaren L, Hawe P, Knudtson ML, Ghali WAAPPROACH Investigators. . Individual-level and neighborhood-level income measures: Agreement and association with outcomes in a cardiac disease cohort Med Care. 2005;43:1116–22
15. Lee DT, Choi KC, Chair SY, Yu DS, Lau ST. Psychological distress mediates the effects of socio-demographic and clinical characteristics on the physical health component of health-related quality of life in patients with coronary heart disease Eur J Prev Cardiol. 2014;21:107–16
16. Norris CM, Spertus JA, Jensen L, Johnson J, Hegadoren KM, Ghali WA, et al Sex and gender discrepancies in health-related quality of life outcomes among patients with established coronary artery disease Circ Cardiovasc Qual Outcomes. 2008;1:123–30
17. Martin BJ, Galbraith PD, Lewin AM, Rabi DM, Anderson TJ, Knudtson ML, et al Sex differences in the association between obesity and quality of life in patients with coronary artery disease Can J Cardiol. 2011;27:S136–7
18. Norris CM, Murray JW, Triplett LS, Hegadoren KM. Gender roles in persistent sex differences in health-related quality-of-life outcomes of patients with coronary artery disease Gend Med. 2010;7:330–9
19. Dueñas M, Ramirez C, Arana R, Failde I. Gender differences and determinants of health related quality of life in coronary patients: A follow-up study BMC Cardiovasc Disord. 2011;11:24
20. Oreopoulos A, McAlister FA, Kalantar-Zadeh K, Padwal R, Ezekowitz JA, Sharma AM, et al The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: A report from APPROACH Eur Heart J. 2009;30:2584–92
21. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, Wu DY. Reverse epidemiology: A spurious hypothesis or a hardcore reality? Blood Purif. 2005;23:57–63
22. Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, et al Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: A systematic review of cohort studies Lancet. 2006;368:666–78
23. Azimi A, Charlot MG, Torp-Pedersen C, Gislason GH, Køber L, Jensen LO, et al Moderate overweight is beneficial and severe obesity detrimental for patients with documented atherosclerotic heart disease Heart. 2013;99:655–60
24. Angerås O, Albertsson P, Karason K, Råmunddal T, Matejka G, James S, et al Evidence for obesity paradox in patients with acute coronary syndromes: A report from the Swedish Coronary Angiography and Angioplasty Registry Eur Heart J. 2013;34:345–53
25. Cemerlic-Adjic N, Pavlovic K, Jevtic M, Velicki R, Kostovski S, Velicki L. The impact of obesity on early mortality after coronary artery bypass grafting Vojnosanit Pregl. 2014;71:27–32
26. Oreopoulos A, Padwal R, McAlister FA, Ezekowitz J, Sharma AM, Kalantar-Zadeh K, et al Association between obesity and health-related quality of life in patients with coronary artery disease Int J Obes (Lond). 2010;34:1434–41
27. Matsumoto C, Miedema MD, Ofman P, Gaziano JM, Sesso HD. An expanding knowledge of the mechanisms and effects of alcohol consumption on cardiovascular disease J Cardiopulm Rehabil Prev. 2014;34:159–71
28. Kaplan MS, Huguet N, Feeny D, McFarland BH, Caetano R, Bernier J, et al Alcohol use patterns and trajectories of health-related quality of life in middle-aged and older adults: A 14-year population-based study J Stud Alcohol Drugs. 2012;73:581–90
29. Valencia-Martín JL, Galán I, Guallar-Castillón P, Rodríguez-Artalejo F. Alcohol drinking patterns and health-related quality of life reported in the Spanish adult population Prev Med. 2013;57:703–7
30. Mukamal KJ, Conigrave KM, Mittleman MA, Camargo CA Jr, Stampfer MJ, Willett WC, et al Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men N Engl J Med. 2003;348:109–18
31. Galán I, Valencia-Martín JL, Guallar-Castillón P, Rodríguez-Artalejo F. Alcohol drinking patterns and biomarkers of coronary risk in the Spanish population Nutr Metab Cardiovasc Dis. 2014;24:189–97

Edited by: Li-Shao Guo

Source of Support: This work was supported by grants from the National Natural Science Foundation of China (No. 81230066, No. 30872173, No. 81172744).

Conflict of Interest: None declared.

Keywords:

Coronary Heart Disease; European Quality of Life 5-dimensions; Health-related Quality of Life; Risk Factor

© 2015 Chinese Medical Association